At a Glance
| Desoxypipradrol | 2-FEA | |
|---|---|---|
| Class | Stimulants | Entactogen, Stimulants |
| Common Dose (insufflated) | 1.5–3.5 mg | 30–40 mg |
| Total Duration | 8.3–40 hrs | 0.7–1.4 hrs |
| Routes | insufflatedoral | insufflated |
Desoxypipradrol, a Stimulants, and 2-FEA, a Entactogen, Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Desoxypipradrol is classified as a Stimulants while 2-FEA is a Entactogen, Stimulants, meaning they approach altered states through different pharmacological mechanisms. They share 32 documented effects in common, with 9 effects unique to Desoxypipradrol and 24 unique to 2-FEA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Desoxypipradrol | 2-FEA | |
|---|---|---|
| Class | Stimulants | Entactogen, Stimulants |
| Common Dose (insufflated) | 1.5–3.5 mg | 30–40 mg |
| Total Duration | 8.3–40 hrs | 0.7–1.4 hrs |
| Routes | insufflatedoral | insufflated |
| Effects | 41 documented | 56 documented |
| Level | Desoxypipradrol | 2-FEA |
|---|---|---|
| Threshold | 0.25 mg | 15 mg |
| Light | 0.5–1.5 mg | 20–30 mg |
| Common | 1.5–3.5 mg | 30–40 mg |
| Strong | 3.5–5 mg | 40–60 mg |
| Heavy | 5 mg | 60 mg |
| Level | Dose |
|---|---|
| Threshold | 0.25 mg |
| Light | 1–2 mg |
| Common | 2–6 mg |
| Strong | 6–8 mg |
| Heavy | 8 mg |
Desoxypipradrol
2-FEA
No direct interaction data available between these substances. This does not mean the combination is safe.